BTA
Click for more information
0.00% 57.0¢ biota holdings limited

Development and commercialisationBiota and Daiichi Sankyo co-own...

  1. outawater
    886 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    28/01/11
    16:53
    Post #: 7805495
    Development and commercialisation
    Biota and Daiichi Sankyo co-own a range of second generation influenza anti-virals, of which Inavir is the lead product.

    Note the use of the phrase "is the lead product". There must be more to come. Toot Toot !

    BTA Price at posting: $1.30 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
ENR Encounter Resources flags latest niobium hits in fresh assay data
right-arrow Created with Sketch.
RZI Raiz to exit Malaysia; focus on Australian business growth
right-arrow Created with Sketch.
MGT Magnetite Mines set to progress DFS for Razorback through deal with JFE Shoji
right-arrow Created with Sketch.
HCH Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
right-arrow Created with Sketch.
PMT High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.